SOM Stock Overview
SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral appliances for the treatment of sleep related disorders in Europe, North America, and the Asia Pacific region.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
SomnoMed Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.21 |
| 52 Week High | AU$1.04 |
| 52 Week Low | AU$0.20 |
| Beta | 1 |
| 1 Month Change | -38.57% |
| 3 Month Change | -52.22% |
| 1 Year Change | -77.37% |
| 3 Year Change | -89.03% |
| 5 Year Change | -88.38% |
| Change since IPO | -97.71% |
Recent News & Updates
Recent updates
SomnoMed Limited (ASX:SOM) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Apr 15
SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?
Mar 04Market Still Lacking Some Conviction On SomnoMed Limited (ASX:SOM)
Dec 21SomnoMed Limited (ASX:SOM) Could Be Riskier Than It Looks
Sep 02Is SomnoMed (ASX:SOM) Using Too Much Debt?
Jun 19It's Unlikely That SomnoMed Limited's (ASX:SOM) CEO Will See A Huge Pay Rise This Year
Nov 18SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?
Sep 27Is SomnoMed (ASX:SOM) Using Debt Sensibly?
May 10Is SomnoMed (ASX:SOM) Using Debt Sensibly?
Oct 26Health Check: How Prudently Does SomnoMed (ASX:SOM) Use Debt?
May 12Could The SomnoMed Limited (ASX:SOM) Ownership Structure Tell Us Something Useful?
Mar 02Have Insiders Been Buying SomnoMed Limited (ASX:SOM) Shares?
Feb 01
Is SomnoMed (ASX:SOM) Using Debt In A Risky Way?
Dec 28Is SomnoMed Limited (ASX:SOM) Trading At A 38% Discount?
Dec 01Analysts Just Published A Bright New Outlook For SomnoMed Limited's (ASX:SOM)
Jul 28SomnoMed Limited (ASX:SOM) Insiders Increased Their Holdings
Jul 14Shareholder Returns
| SOM | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 2.4% | -2.4% | -3.0% |
| 1Y | -77.4% | 12.6% | 3.9% |
Return vs Industry: SOM underperformed the Australian Medical Equipment industry which returned 12.6% over the past year.
Return vs Market: SOM underperformed the Australian Market which returned 3.9% over the past year.
Price Volatility
| SOM volatility | |
|---|---|
| SOM Average Weekly Movement | 19.5% |
| Medical Equipment Industry Average Movement | 10.3% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: SOM's share price has been volatile over the past 3 months.
Volatility Over Time: SOM's weekly volatility has increased from 13% to 19% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | Neil Verdal-Austin | somnomed.com/au/ |
SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral appliances for the treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. Its flagship product SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs are cleaning tablets, developed to clean oral appliances safely and effectively.
SomnoMed Limited Fundamentals Summary
| SOM fundamental statistics | |
|---|---|
| Market cap | AU$29.26m |
| Earnings (TTM) | -AU$10.51m |
| Revenue (TTM) | AU$88.77m |
0.3x
P/S Ratio-2.8x
P/E RatioIs SOM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SOM income statement (TTM) | |
|---|---|
| Revenue | AU$88.77m |
| Cost of Revenue | AU$33.95m |
| Gross Profit | AU$54.82m |
| Other Expenses | AU$65.33m |
| Earnings | -AU$10.51m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.077 |
| Gross Margin | 61.76% |
| Net Profit Margin | -11.84% |
| Debt/Equity Ratio | 40.0% |
How did SOM perform over the long term?
See historical performance and comparison